Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR‐tyrosine kinase inhibitor treatment response

BACKGROUND: Epidermal growth factor receptor (EGFR) gene mutation is a reliable predictive factor for response to EGFR‐tyrosine kinase inhibitors (TKIs). The quantified EGFR value may also predict response and survival within an EGFR mutated group. METHODS: We conducted a retrospective study of 836...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Ha Young, Oh, Hyung Joo, Kim, Ki‐Hyun, Kim, Tae‐Ok, Park, Cheol‐Kyu, Shin, Hong‐Jun, Lim, Jung‐Hwan, Kwon, Yong‐Soo, Oh, In‐Jae, Kim, Yu‐Il, Lim, Sung‐Chul, Kim, Young‐Chul, Choi, Yoo‐Duk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093171/
https://www.ncbi.nlm.nih.gov/pubmed/27755804
http://dx.doi.org/10.1111/1759-7714.12378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093171/
https://www.ncbi.nlm.nih.gov/pubmed/27755804
http://dx.doi.org/10.1111/1759-7714.12378

Ejemplares similares